Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05206864 · ClinicalTrials.gov registry record · NA
Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults
A NA study, sponsored by Solarea Bio.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05206864: Completed NA study, sponsored by Solarea Bio.
NCT05206864 is a NA study that has completed, run by Solarea Bio. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05206864, a NA study, has completed, sponsored by Solarea Bio.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The aim of the trial is to determine if the synbiotic (prebiotic and probiotic), provided twice daily (capsule) is safe and tolerable in healthy adults.
Primary Outcome
Occurrence of adverse events defined as a Grade II-IV toxicity (FDA's Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Subjects Enrolled in Preventative Vaccine Clinical Trials, September 2007), that are possibly or probably related to administration of SBD111
Interventions
- OTHER Placebo
- OTHER Medical Food: SBD111
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-02-05 |
| Phase | NA |
What the finished NCT05206864 record still lists
NCT05206864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05206864 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05206864 about?
NCT05206864 is a clinical study titled "Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults". The aim of the trial is to determine if the synbiotic (prebiotic and probiotic), provided twice daily (capsule) is safe and tolerable in healthy adults.
What is the current status of trial NCT05206864?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2021-09-01. Estimated completion is 2022-02-05.
What interventions are being tested in trial NCT05206864?
The interventions under investigation include: Placebo (OTHER), Medical Food: SBD111 (OTHER).
Who is sponsoring clinical trial NCT05206864?
This trial is sponsored by Solarea Bio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05206864's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI